Founded in 2001 and headquartered in Romainville, France, Theraptosis designs and develops drugs targeting various areas such as anti-angiogenesis, targeted tumor cell killing, auto-immunity, and neuroprotection. Their focus is on creating treatments for cancer and neurodegenerative diseases, offering research and development programs in these areas.